Top Sell
Wertpapier | Buy | Sell ▼ | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
---|---|---|---|---|---|---|---|
Moleculin Biotech Inc | 3 | 25 | 0 | 2 | 0,41 € | 18,42 € | 4393,66 % |
Evoke Pharma Inc. | 0 | 24 | 0 | 1 | 0,37 € | - | - |
Trevena Inc. | 2 | 23 | 0 | 3 | 0,15 € | 6,48 € | 4136,60 % |
AEterna Zentaris Inc. | 2 | 22 | 0 | 2 | 1,87 € | 8,51 € | 355,10 % |
Novan Inc | 0 | 20 | 0 | 0 | 0,001 € | - | - |
Mirati Therapeutics Inc. | 1 | 10 | 0 | 0 | 53,84 € | 78,43 € | 45,67 % |
Bellicum Pharmaceuticals Inc. | 0 | 10 | 0 | 0 | 0,064 € | - | - |
Minerva Neurosciences Inc. | 0 | 9 | 0 | 0 | 2,48 € | - | - |
Organovo Holdings Inc. | 0 | 8 | 0 | 0 | 0,54 € | - | - |
Cyclacel Pharmaceuticals Inc. | 2 | 8 | 0 | 0 | 0,22 € | 14,66 € | 6565,59 % |
Cara Therapeutics Inc. | 10 | 6 | 0 | 2 | 0,32 € | 4,61 € | 1348,46 % |
Glycomimetics Inc. | 3 | 6 | 0 | 3 | 0,15 € | 9,13 € | 5909,61 % |
Bluebird Bio Inc. | 7 | 6 | 3 | 0 | 0,54 € | 5,47 € | 922,11 % |
Cellectar BioSciences Inc. | 5 | 4 | 0 | 0 | 1,98 € | 11,09 € | 460,18 % |
Fate Therapeutics Inc. | 4 | 3 | 1 | 0 | 3,22 € | 7,31 € | 127,38 % |
Larimar Therapeutics Inc. | 2 | 3 | 0 | 0 | 7,05 € | 58,50 € | 729,79 % |
Bristol-Myers Squibb | 7 | 3 | 0 | 1 | 44,91 € | 67,64 € | 50,61 % |
Atara Biotherapeutics Inc. | 2 | 2 | 0 | 0 | 0,37 € | 3,00 € | 716,55 % |
Uniqure B.V. | 1 | 2 | 0 | 0 | 5,61 € | 11,00 € | 96,01 % |
Sage Therapeutics Inc. | 5 | 2 | 0 | 0 | 7,11 € | 21,44 € | 201,35 % |
Coherus Bioscien. | 1 | 2 | 1 | 0 | 1,29 € | - | - |
Agenus Inc. | 4 | 2 | 1 | 0 | 0,41 € | 37,02 € | 8846,83 % |
Alterity Therapeutics Ltd. ADR | 0 | 1 | 0 | 0 | 0,99 € | - | - |
D.Western Therapeutics Institute Inc | 0 | 1 | 0 | 0 | 0,40 € | - | - |
Immuron | 0 | 1 | 0 | 0 | 2,24 € | - | - |